albuterol has been researched along with Insulin Resistance in 4 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Obesity is a metabolic disorder that predisposes to numerous diseases and has become a major global public health concern." | 1.48 | Obesity alters the uterine environment before pregnancy. ( Bazzano, MV; Berón de Astrada, M; Elia, EM; Martinez, N; Sarrible, GB, 2018) |
| "Insulin resistance is a condition in which there is a defect in insulin actions to induce glucose uptake into the cells." | 1.48 | Prolonged stimulation of β ( Mangmool, S; Nishida, M; Nishimura, A; Parichatikanond, W, 2018) |
| "Insulin resistance was assessed using homeostasis model assessment (HOMA-IR)." | 1.34 | The vascular effects of metabolic impairment clusters in subjects of different ethnicities. ( Chowienczyk, P; Forrester, T; Kalra, L; Rambaran, C; Ritter, J; Shah, A; Wilks, R, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bazzano, MV | 1 |
| Sarrible, GB | 1 |
| Martinez, N | 1 |
| Berón de Astrada, M | 1 |
| Elia, EM | 1 |
| Parichatikanond, W | 1 |
| Nishimura, A | 1 |
| Nishida, M | 1 |
| Mangmool, S | 1 |
| Rambaran, C | 2 |
| Chowienczyk, P | 2 |
| Ritter, J | 2 |
| Shah, A | 2 |
| Wilks, R | 1 |
| Forrester, T | 2 |
| Kalra, L | 2 |
| Iveson, E | 1 |
| Sherwood, R | 1 |
1 trial available for albuterol and Insulin Resistance
| Article | Year |
|---|---|
An international matched cohort study of the contribution of metabolic impairments to subclinical atherosclerosis in United Kingdom and Jamaican African-Caribbeans.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Black People; Body Mass Index; Carotid Arteries; Carotid | 2008 |
3 other studies available for albuterol and Insulin Resistance
| Article | Year |
|---|---|
Obesity alters the uterine environment before pregnancy.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Cell Proliferation; Diet; Down-Regulation; | 2018 |
Prolonged stimulation of β
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Cells, Cultured; Formoterol Fumarate; Glucose; Gluco | 2018 |
The vascular effects of metabolic impairment clusters in subjects of different ethnicities.
Topics: Adult; Aged; Albuterol; Black People; Blood Glucose; Blood Pressure; Body Composition; Carotid Arter | 2007 |